Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2016 2
2017 4
2018 6
2019 6
2020 7
2021 8
2022 12
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean charleenardin (3 results)?
Cutaneous vasculitis associated with mycosis fungoides.
Nardin C, Lesage C, Goubeau E, Aubriot-Lorton MH, Lacheretz-Szablewski V, Ortonne N, Saizonou I, Aubin F, Dereure O, Dalac-Rat S. Nardin C, et al. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e204-e206. doi: 10.1111/jdv.18657. Epub 2022 Oct 20. J Eur Acad Dermatol Venereol. 2023. PMID: 36222460 No abstract available.
Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
Durand MA, Drouin A, Mouchard A, Durand L, Esnault C, Berthon P, Tallet A, Le Corre Y, Hainaut-Wierzbicka E, Blom A, Saiag P, Beneton N, Bens G, Nardin C, Aubin F, Dinulescu M, Collin C, Fromont-Hankard G, Cribier B, Laurent-Roussel S, Cokelaere K, Houben R, Schrama D, Peixoto P, Hervouet E, Bachiri K, Kantar D, Coyaud E, Guyétant S, Samimi M, Touzé A, Kervarrec T. Durand MA, et al. Among authors: nardin c. J Invest Dermatol. 2023 Oct;143(10):1937-1946.e7. doi: 10.1016/j.jid.2023.02.038. Epub 2023 Apr 8. J Invest Dermatol. 2023. PMID: 37037414
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Nardin C, Laheurte C, Puzenat E, Boullerot L, Ramseyer M, Marguier A, Jacquin M, Godet Y, Aubin F, Adotevi O. Nardin C, et al. J Invest Dermatol. 2022 Feb;142(2):435-444. doi: 10.1016/j.jid.2021.07.160. Epub 2021 Aug 2. J Invest Dermatol. 2022. PMID: 34352265 Free article.
PD-L1 in circulating exosomes of Merkel cell carcinoma.
Zanella A, Vautrot V, Aubin F, Avoscan L, Samimi M, Garrido C, Gobbo J, Nardin C. Zanella A, et al. Among authors: nardin c. Exp Dermatol. 2022 Jun;31(6):869-877. doi: 10.1111/exd.14520. Epub 2022 Jan 27. Exp Dermatol. 2022. PMID: 34994009
Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
Nardin C, Hennemann A, Diallo K, Funck-Brentano E, Puzenat E, Heidelberger V, Jeudy G, Samimi M, Lesage C, Boussemart L, Peuvrel L, Rouanet J, Brunet-Possenti F, Gerard E, Seris A, Jouary T, Saint-Jean M, Puyraveau M, Saiag P, Aubin F. Nardin C, et al. Cancers (Basel). 2023 Jul 10;15(14):3564. doi: 10.3390/cancers15143564. Cancers (Basel). 2023. PMID: 37509227 Free PMC article.
Clinical Features, Histological Characteristics, and Disease Outcomes of Mycosis Fungoides in Children and Adolescents: A Nationwide Multicentre Cohort of 46 Patients.
Welfringer-Morin A, Barroil M, Fraitag S, Szablewski V, Boccara O, Lacour JP, Chiaverini C, Bagot M, Ram-Wolff C, Vignon-Pennamen MD, Dalle S, D'incan M, Amatore F, Beylot-Barry M, Vergier B, Mazereeuw-Hautier J, Tedbirt B, Quereux G, Carpentier O, Skowron F, Bertrand Y, Van Eeckhout P, Dekeuleneer V, Nardin C, Adamski H, Ingen-Housz-Oro S, Dereure O, Bodemer C. Welfringer-Morin A, et al. Among authors: nardin c. Dermatology. 2023;239(1):132-139. doi: 10.1159/000526788. Epub 2022 Nov 4. Dermatology. 2023. PMID: 36349768
[Adverse effects of immune checkpoint inhibitors used to treat melanoma and other cancer].
Jacquin-Porretaz C, Nardin C, Puzenat E, Roche-Kubler B, Aubin F; Comité de suivi des effets secondaires des immunothérapies anti-cancéreuses(CSESIAC). Jacquin-Porretaz C, et al. Among authors: nardin c. Presse Med. 2017 Sep;46(9):808-817. doi: 10.1016/j.lpm.2017.05.032. Epub 2017 Jul 3. Presse Med. 2017. PMID: 28683958 Review. French.
Increased Levels of Interleukin-17A Exosomes in Psoriasis.
Jacquin-Porretaz C, Cordonnier M, Nardin C, Boullerot L, Chanteloup G, Vautrot V, Adotevi O, Garrido C, Gobbo J, Aubin F. Jacquin-Porretaz C, et al. Among authors: nardin c. Acta Derm Venereol. 2019 Nov 1;99(12):1143-1147. doi: 10.2340/00015555-3300. Acta Derm Venereol. 2019. PMID: 31449317 Free article.
50 results